Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
New data from ADA 2026 reveal that assumptions around age, weight, and gestational history are leaving too many T1D patients misclassified — and the clinical consequences are preventable. Our modern ...
Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including ...
Type 1 diabetes (T1D) is a chronic autoimmune disease that involves the destruction of insulin-producing β-cells in the pancreas, leading to insufficient insulin production and blood glucose control.
Continued site activation in registrational SAFEGUARD trial of SAB-142; enrollment ongoing and on track to be completed by end of 2026 with topline data expected in 2H 2027 Reported additional Phase 1 ...
Add Yahoo as a preferred source to see more of our stories on Google. ANKENY, Iowa — Thousands of Iowans will gather next month for a walk that's about more than steps. It's about hope. The ...
All 4 T1D participants receiving SAB-142 showed C-peptide preservation with 3 of the 4 participants showing a super responder profile concomitant with T cell exhaustion T1D participants receiving ...
Over a six-week period, Nick Agostino lost an inordinate amount of weight, was constantly thirsty, continually waking up with severe cramps and becoming more and more lethargic. “It was progressively ...
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system ...
The Breakthrough T1D San Francisco Gala returns for its 27th year, bringing the T1D community together for "A Magical Night Beneath the Cherry Blossoms" at the iconic San Francisco City Hall. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results